|
74
|
276
|
5meqA |
Human leukocyte antigen a02 presenting ilakflhtl |
|
72
|
276
|
5menA |
Human leukocyte antigen a02 presenting ilakflhwl, in complex with cognate t-cell receptor |
|
66
|
271
|
5ymvA |
Crystal structure of 9-mer peptide from influenza virus in complex with bf2*1201 |
|
73
|
276
|
5meoA |
Human leukocyte antigen presenting ilgkflhrl |
|
70
|
276
|
5m02A |
Crystal structure of murine p14 tcr / h-2db with pf, modified gp33 peptide from lcmv |
|
72
|
276
|
5m01A |
Crystal structure of murine p14 tcr/ h-2db complex with pa, modified gp33 peptide from lcmv |
|
71
|
276
|
5m00A |
Crystal structure of murine p14 tcr complex with h-2db and y4a, modified gp33 peptide from lcmv |
|
57
|
276
|
5knmA |
Human leukocyte antigen f (hla-f) presents peptides and regulates immunity through interactions with nk-cell receptors |
|
65
|
274
|
5jwdA |
Crystal structure of h-2db in complex with the lcmv-derived gp392-401 peptide |
|
59
|
272
|
5jziA |
Crystal structure of 1406 tcr bound to hla-a2 with hcv 1406-1415 antigen peptide |
|
68
|
276
|
5jhdA |
Crystal structure of ls10-tcr/m1-hla-a*02 complex |
|
68
|
276
|
5jweA |
Crystal structure of h-2db in complex with the lcmv-derived gp92-101 peptide |
|
70
|
276
|
5j6hA |
Recognition of the mhc class ib molecule h2-q10 by the natural killer cell receptor ly49c |
|
77
|
275
|
5iueA |
Human leukocyte antigen f (hla-f) presents peptides and regulates immunity through interactions with nk-cell receptors |
|
78
|
276
|
5ib2A |
Crystal structure of hla-b*27:05 complexed with the self-peptide pvipr |
|
73
|
276
|
5ib5A |
Crystal structure of hla-b*27:09 complexed with the self-peptide pvipr and copper |
|
78
|
276
|
5iehA |
Structure of hla-b*40:02 in complex with the phosphorylated endogenous peptide ref(p)skepel |
|
82
|
276
|
5ib3A |
Crystal structure of hla-b*27:05 complexed with the self-peptide pvipr and copper |
|
75
|
276
|
5iekA |
Structure of hla-b*40:02 in complex with the endogenous peptide refskepel |
|
67
|
276
|
5hyjA |
1e6 tcr in complex with hla-a02 carrying aqwgpdpaaa |
|
70
|
274
|
5hgbA |
Hla*a2402 complexed with hiv nef138 8mer epitope |
|
76
|
274
|
5hhpA |
Crystal structure of hla-a*0201 in complex with m1-g4e |
|
80
|
274
|
5hhqA |
Crystal structure of hla-a*0201 in complex with m1-l3w |
|
69
|
274
|
5gsxA |
Mouse mhc class i h-2kd with a mers-cov-derived peptide 142-2 |
|
71
|
274
|
5gsbA |
Mouse mhc class i h-2kd with a mers-cov-derived peptide 37-3 |
|
73
|
274
|
5fdwA |
Structure of hla-a2:01 with peptide y10l |
|
65
|
274
|
6ghnA |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p9-phe. |
|
68
|
274
|
6gl1A |
Hla-e*01:03 in complex with the hiv epitope, rl9hiv |
|
73
|
274
|
6gh4A |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p2-gln. |
|
72
|
274
|
6ggmA |
Hla-e*01:03 in complex with the mtb44 peptide variant: mtb44*p2-phe. |
|
59
|
265
|
6fgbA |
Human fcrn extra-cellular domain complexed with fab fragment of rozanolixizumab |
|
52
|
274
|
6enyF |
Structure of the human plc editing module |
|
78
|
275
|
6ei2A |
Crystal structure of hla-a68 presenting a c-terminally extended peptide |
|
76
|
276
|
6d2tA |
Hla-b*57:01 presenting lalltgvrw |
|
77
|
276
|
6d2bA |
Hla-b*57:01 presenting lsdstardvtw |
|
74
|
276
|
6d29A |
Hla-b*57:01 presenting tsmsfvprpw |
|
78
|
276
|
6d2rA |
Hla-b*57:01 presenting gsfdysgvhlw |
|
68
|
265
|
6c99A |
Crystal structure of fcrn bound to ucb-303 |
|
64
|
264
|
6c98A |
Crystal structure of fcrn bound to ucb-84 |
|
68
|
265
|
6c97A |
Crystal structure of fcrn at ph3 |
|
79
|
276
|
6bxqB |
Crystal structure of hla-b*57:01 with an hiv peptide rkv |
|
77
|
275
|
6bxpA |
Crystal structure of hla-b*57:01 with a modified hiv peptide rkv-kyn |
|
75
|
275
|
6bj3A |
Tcr55 in complex with hiv(pol448-456)/hla-b35 |
|
77
|
274
|
6bj8A |
Tcr55 in complex with pep20/hla-b35 |
|
57
|
276
|
6bj2A |
Tcr589 in complex with hiv(pol448-456)/hla-b35 |
|
66
|
274
|
6amtA |
Human class i mhc hla-a2 in complex with synthetic peptide mmwdrglgmm |
|
80
|
275
|
6at5A |
Crystal structure of hla-b*07:02 in complex with an ny-eso-1 peptide |
|
67
|
275
|
6avfH |
Crystal structure of the kfj5 tcr-ny-eso-1-hla-b*07:02 complex |
|
70
|
275
|
6am5A |
Crystal structure of dmf5 tcr bound to hla-a2 presenting synthetic peptide smlgigivpv |
|
60
|
274
|
6at9A |
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the human major histocompatibility complex class i molecule hla-a*0101 |
